Read + Share
Amedeo Smart
Independent Medical Education
Thomalla D, Beckmann L, Grimm C, Oliverio M, et al. Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies. Blood 2022;140:2113-2126.PMID: 35704690
Email
LinkedIn
Facebook
Twitter
Privacy Policy